Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 5Recruiting 5Active not recruiting 3Terminated 2Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Neoplasms 4Esophageal Squamous Cell Carcinoma 2Pain, Postoperative 1Loco-regional Esophageal Cancer 1Carcinoma, Squamous Cell 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 8Radiotherapy 7Fluorouracil 6Neoadjuvant Therapy 4Irinotecan 4pembrolizumab 3Paclitaxel 3Gefitinib 3Carboplatin 3toripalimab 2spartalizumab 2Oxaliplatin 2Nivolumab 2Esophagectomy 2Docetaxel 2vandetanib 1tislelizumab 1sitravatinib 1ribociclib 1oblimersen 1nazartinib 1liposomal doxorubicin 1apatinib 1Surgical Procedures, Operative 1SGN-LIV1A 1Proton Therapy 1Pemetrexed 1Panitumumab 1Nutritional Support 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Esophageal Squamous Cell Carcinoma × Esophagectomy × Clear all
NCT03223662 2018-10-30

Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
2 enrolled 6 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT01740375 2017-08-29

ESOPRESSO

Asan Medical Center

Phase 3 Terminated
486 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡